Cubist Systematic Strategies LLC Takes Position in Aurora Cannabis Inc. (NASDAQ:ACB)

Cubist Systematic Strategies LLC acquired a new stake in Aurora Cannabis Inc. (NASDAQ:ACB) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 10,865 shares of the company’s stock, valued at approximately $50,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of ACB. Concurrent Investment Advisors LLC bought a new stake in shares of Aurora Cannabis during the 1st quarter worth about $90,000. Headlands Technologies LLC bought a new stake in shares of Aurora Cannabis during the 1st quarter worth about $166,000. Virtu Financial LLC bought a new stake in shares of Aurora Cannabis during the 1st quarter worth about $727,000. Cetera Advisors LLC bought a new stake in shares of Aurora Cannabis during the 1st quarter worth about $59,000. Finally, Baader Bank Aktiengesellschaft boosted its holdings in shares of Aurora Cannabis by 121.1% during the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after buying an additional 12,481 shares during the period. Institutional investors own 47.63% of the company’s stock.

Aurora Cannabis Stock Performance

Shares of ACB stock opened at $5.55 on Thursday. The company has a market capitalization of $302.73 million, a price-to-earnings ratio of -3.96 and a beta of 1.86. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.03 and a current ratio of 3.76. The company has a 50-day simple moving average of $5.93 and a 200 day simple moving average of $6.06. Aurora Cannabis Inc. has a 52 week low of $2.84 and a 52 week high of $9.35.

Aurora Cannabis (NASDAQ:ACB) last announced its earnings results on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.24. The business had revenue of $67.27 million during the quarter, compared to the consensus estimate of $55.98 million. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. On average, sell-side analysts predict that Aurora Cannabis Inc. will post -0.37 earnings per share for the current year.

Aurora Cannabis Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.